Corrigendum to: “Identification of Potential Molecular Targets of Doxorubicin for Application in Skin Cancer: A Network Pharmacology and Molecular Docking Perspective”

Materials and Methods, subheading “Molecular Docking”: The original sentence “MOE is a freely available Scientific Vector Language (SVL)-based drug discovery tool that has a user-friendly interface” has been corrected to “MOE (Chemical Computing Group Inc., Montreal, Quebec, Canada) is a Scientific Vector Language (SVL)-based drug discovery tool that has a user-friendly interface.”

Acknowledgments: The following acknowledgments have been added: “The authors sincerely acknowledge Dr. Mohemmed Faraz Khan (Molecular Design Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland; and Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Integral University, Lucknow, India) for conducting the molecular docking studies presented in this work. The authors also gratefully acknowledge Jamia Hamdard, New Delhi, India, for providing the infrastructure and facilities necessary to carry out this research.”